World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
108
Citations
60717
World Ranking
570
National Ranking
11

Psychology

D-Index
104
Citations
58957
World Ranking
507
National Ranking
26

Medicine

D-Index
108
Citations
60848
World Ranking
5893
National Ranking
165

David Ames publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where David Ames sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 344 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 34 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–705 publications: 5 scientists 706+ publications: 100 scientists
31 publications 706+

This scientist: 819 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 706 publications or more.

David Ames D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where David Ames sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 559 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 87 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 79 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 104 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

David Ames is affiliated with the University of Melbourne in Australia and has an extensive research portfolio primarily in the field of Medicine. Their work spans various subfields including Psychiatry and Mental Health, Molecular Biology, Physiology, Cardiology and Cardiovascular Medicine, and Genetics.

The main topics of David Ames's research include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's Disease Research and Treatments
  • Functional Brain Connectivity Studies
  • Nutritional Studies and Diet
  • Genetic Associations and Epidemiology
  • Metabolomics and Mass Spectrometry Studies
  • Advanced Neuroimaging Techniques and Applications

David Ames has published numerous papers in high-profile journals, with recent notable publications including:

  • Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture, 2020, Nature Communications
  • Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort, 2022, Alzheimer's & Dementia
  • Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease, 2021, Journal of Alzheimer's Disease Reports
  • Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia, 2021, Journal of Neuroimaging
  • Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease, 2020, Nature Communications

The frequent co-authors who have collaborated extensively with David Ames are:

  • Colin L. Masters
  • Ralph N. Martins
  • Victor L. Villemagne
  • Christopher C. Rowe
  • Stephanie R. Rainey-Smith

David Ames's research has been published across several respected venues, with repeated contributions to:

  • Alzheimer's & Dementia
  • Nature Communications
  • Journal of Alzheimer's Disease
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring

In addition to journal publications, David Ames has contributed to book literature, including a publication from Cambridge University Press titled Guide to the Psychiatry of Old Age published in 2022.

Best Publications

  • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

    Gill Livingston;Gill Livingston;Jonathan Huntley;Andrew Sommerlad;Andrew Sommerlad;David Ames

  • Dementia prevention, intervention, and care

    Gill Livingston;Gill Livingston;Andrew Sommerlad;Vasiliki Orgeta;Sergi G Costafreda;Sergi G Costafreda

  • Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

    Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown

  • Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

    Craig W Ritchie;Ashley I Bush;Andrew J Mackinnon;Steve Macfarlane

  • The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

    Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio

  • Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

    Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat

  • Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease

    Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis

  • Common genetic variants influence human subcortical brain structures.

    Derrek P. Hibar;Jason L. Stein;Jason L. Stein;Miguel E. Renteria;Alejandro Arias-Vasquez

  • Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018

    L. Evered;L. Evered;B. Silbert;B. Silbert;D.S. Knopman;D.A. Scott;D.A. Scott

  • Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

    Lars Lannfelt;Kaj Blennow;Henrik Zetterberg;Stellan Batsman

  • The genetic architecture of the human cerebral cortex

    Katrina L. Grasby;Neda Jahanshad;Jodie N. Painter;Lucía Colodro-Conde

  • Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function

    Gail Davies;Max Lam;Sarah E. Harris;Joey W. Trampush

  • A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia

    Henry Brodaty;David Ames;John Snowdon;Michael Woodward

  • The prevalence of anxiety in older adults: Methodological issues and a review of the literature

    Christina Bryant;Henry Jackson;David Ames

  • Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.

    Gaël Chételat;Victor L. Villemagne;Pierrick Bourgeat;Kerryn E. Pike

  • Increased risk of cognitive impairment in patients with diabetes is associated with metformin

    Eileen Moore;Eileen Moore;Alastair Mander;David Ames;Mark A. Kotowicz;Mark A. Kotowicz;Mark A. Kotowicz

  • Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease

    James D. Doecke;James D. Doecke;Simon M. Laws;Simon M. Laws;Noel G. Faux;Noel G. Faux;William Wilson

  • Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)

    G. Davies;N. Armstrong;J. C. Bis;J. Bressler

  • Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort

    Samantha Burnham;Petra Graham;Bill Wilson;David Ames

  • The amyloid precursor protein of Alzheimer's disease is released by human platelets.

    A I Bush;R N Martins;B Rumble;R Moir

Frequent Co-Authors

Ralph N. Martins
Ralph N. Martins Edith Cowan University
Christopher C. Rowe
Christopher C. Rowe University of Melbourne
Victor L. Villemagne
Victor L. Villemagne University of Pittsburgh
Kathryn A. Ellis
Kathryn A. Ellis University of Melbourne
Colin L. Masters
Colin L. Masters University of Melbourne
Olivier Salvado
Olivier Salvado Commonwealth Scientific and Industrial Research Organisation
Paul Maruff
Paul Maruff University of Melbourne
Cassandra Szoeke
Cassandra Szoeke University of Melbourne
Ashley I. Bush
Ashley I. Bush Florey Institute of Neuroscience and Mental Health
Henry Brodaty
Henry Brodaty University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore studying Psychology in the USA, it’s important to consider the range of online degrees and career pathways available in this field. Graduate qualifications in counseling, clinical psychology, or therapy are common options for those aiming for professional licensure or advanced roles.

Affordability can play a major role when selecting a program. There are opportunities to find the cheapest counseling programs in San Diego or consider options further north, such as affordable counseling degrees in Seattle. If you prefer a Southwestern location, review the cheapest counseling programs in Tempe. For those interested in the South, a variety of affordable counseling programs in Texas are also available.

Choosing the right path involves balancing cost, flexibility, and your future career goals—whether you plan to become a counselor, clinical psychologist, or pursue work in related fields such as human services or social work. Researching your options and considering online or hybrid programs can open up many opportunities while helping you manage tuition and expenses.

Best Scientists Citing David Ames

Trending Scientists